Printer Friendly

Articles from M2 Pharma (June 30, 2020)

1-40 out of 40 article(s)
Title Author Type Words
Akcea Therapeutics names new chief compliance officer. 162
Aran Biomedical elects new VP of Sales & Business Development (US). 171
Arya receives shareholder approval for business combination with Immatics. 257
Australian states close borders to Victoria as COVID-19 cases surge. 210
Beckman Coulter's SARS-CoV-2 IgG antibody test wins FDA's EUA. 209
Bryn Pharma adds new board members. 200
Citi and Citi Foundation Reach Over USD 100m in Commitments for COVID-19 Community Relief and Economic Recovery Efforts. 324
Cold Spring Harbor Laboratory Cites New Evidence for How Blood Clots May Form in Very Ill COVID-19 Patients. 374
Cold Spring Harbor Laboratory states sticky, pathogen-trapping webs produced by neutrophils cells are associated with the most severe cases of COVID-19. 239
COVID-19 Will Change the Global Economy Forever, According to Mubadala and Bridgewater CEOs. 491
DFDS announces new plan to adapt to market conditions amid COVID-19 pandemic. 380
Direct Supply Partners with SafelyYou to Reduce Falls in Senior Living Amid COVID-19 and Beyond. 647
easyJet plans to close three airport bases and shrink workforce. 159
Future Fund extended to include firms that have moved their HQ overseas. 175
GetInsured retires about USD1.6m of medical debt in New Jersey amidst COVID-19 pandemic. 199
Groups Offer Addiction Treatment Needs Assessment as COVID-19 Pandemic Makes Access to Addiction Treatment Services Challenging. 448
Health Canada Allows COVID-19 Patients with Respiratory Failure to Be Given NuvOx Pharma's Oxygen Therapeutic in Phase IIa Clinical Trial. 155
Intertek Expands Personal Protective Equipment Services and COVID-19 Solutions with N95 Respirator Precertification Testing. 204
IPA Confirms Discovery of Fully Human, Potent, Neutralizing Antibodies Targeting SARS-CoV-2. 406
Konica Minolta Precision Medicine's Ambry Genetics Launches Care for COVID Programme. 477
Lockdown tightened in Leicester, UK as COVID-19 cases rise. 155
Los Angeles county to close beaches for 4 July weekend to prevent spread of COVID-19 due to crowding. 231
Luminex submits EUA with FDA for xMAP SARS-CoV-2 Multi-Antigen IgG assay to detect antibodies in patients. 203
Maskco Technologies signs distribution agreement with Gredale LLC for the N95 MTech respirators during COVID-19 crisis. 158
New Zealand to host virtual APEC summit in 2021 due to COVID-19 pandemic effects. 180
NoHo Partners' board to grant 2.4 million special rights to Tesi as a part of the COVID-19 financing package completed. 255
PEEL Therapeutics Sees Possible New Treatment for COVID-19. 726
Pharmacy Technician Certification Board Teams with American Pharmacists Association to Develop Immunization Credential Programme for Pharmacy Technicians. 436
Pharmacy Technician Certification Board, American Pharmacists Association collaborate on pharmacy technicians' immunisation credential program. 185
Priority Health Offers USD 0 Cost Share Treatment for COVID-19 and All Virtual Visits Through End of Year. 271
Rest of the current World Rugby Sevens Series cancelled due to COVID-19 pandemic. 162
RevImmune Launches Phase II Trial of the T-Cell Growth Factor CYT107 for COVID-19. 586
Sabar Health collaborates with Vaica Medical to offer Remote Patient Management solutions. 170
Thrombosis Research Institute Announce ETHIC Trial to Evaluate the Potential Benefits of Early Administration of LMWH in Patients with COVID-19. 232
TRI commences ETHIC trial to evaluate potential benefits of early administration of LMWH in patients with COVID-19. 227
Two Indian states will continue COVID-19 lock down as cases rise. 178
UK's PM expected to announce GBP5bn infrastructure scheme to boost economy. 153
US FDA approves SFA Therapeutics' clinical trial for treatment of 'the appearance of the structure of skin with plaques due to psoriasis'. 203
US FDA, FTC Warn Companies to Stop Selling Unapproved COVID-19 Products. 243
Washington University slightly lowers its projection of US COVID-19 deaths. 211

Terms of use | Privacy policy | Copyright © 2024 Farlex, Inc. | Feedback | For webmasters |